Health Services Research and Practice: Pharmaceuticals Andy Stergachis, Ph.D. R.Ph. Epidemiology and Pharmacy.

Slides:



Advertisements
Similar presentations
Our role in the U.S. pharmaceutical supply chain:
Advertisements

Patient Safety What is it? Why is it important? What are we doing? What is my part to play?
Walsall Healthcare NHS Trust Medicines Management.
UNITED SPINAL ASSOCIATION AUGUST, 2014 Biologics & Biosimilars: An Overview 1.
The Challenges for Medicines Optimisation
SCHEDULING OF MEDICINES SAPRAA 13 June Scheduling of Medicines Ephedrine Pseudoephedrine D-nor-pseudoephedrine.
An introduction to Medical Communications
Managing Medicines Use by PBC Groups in West Hertfordshire Dr Alison Davies.
Innovations: Using a Clinical Pharmacist as a Vehicle for Successful P4P Outcomes Lisa Meland, B.S., PharmD. Helen Pervanas, R.Ph. WellPoint-WellPoint.
PARMEE DEDHIA M.Pharm (Clinical Pharmacy), NMIMS
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
Pharmacoepidemiology: Goals and Methods Sean Hennessy, PharmD, PhD Assistant Professor of Epidemiology & Pharmacology Center for Clinical Epidemiology.
Postmarketing Risk Assessment of Drug Products Division of Drug Risk Evaluation Office of Drug Safety Center for Drug Evaluation and Research.
Clinical Pharmacy Basma Y. Kentab MSc..
INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center
Cross-Border Internet Pharmacy: No Place to Buy Drugs Durhane Wong-Rieger, PhD Consumer Advocare Network.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
DSaRM Advisory Committee May 18, 2005 Active Surveillance for Drug Safety Signals: Past, Present, and Future Mary Willy, Ph.D. Division of Drug Risk Evaluation.
CH 1. Factors accounting for the growth of importance in the health sector  Global health and longevity gains  Expansion of health sector throughout.
Pharmaceutical Epistemology Jim Golden, Ph.D. Global Lead, Healthcare Data Analytics Accenture
Yesterday, today, and tomorrow
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
Impact Health NDAC Meeting Stewart Levy R.Ph. January 14, 2005.
Importance of Clinical Pharmacy service in Egypt's Hospitals
Quantitative Evaluation of Drug Name Safety Using Close-to-Reality Simulated Pharmacy Practice Sean Hennessy, PharmD, PhD Assistant Professor of Epidemiology.
Pharmaceutical Overview 1. Pharmaceutical Overview (1) Pharmaceuticals partially covered through various health insurance schemes Public insurance provision.
Pharmacy Practice Introduction
PHARMACOVIGILANCE AND CLINICAL TRIALS DIVISION 20 August 2015 Victoria Falls Protecting Your Right to Quality Medicines and Medical Devices.
PROPRIETARY NAME EVALUATION AT FDA Jerry Phillips, RPh Associate Director for Medication Error Prevention Office of Drug Safety December 4, 2003.
From the Lab to Market Unit 3.04 Understanding Biotechnology research & Development.
In 2003, Medicaid spent $33.7 billion on drugs (19% of national spending for drugs and more than 10% of the Medicaid budget) Medicaid expenditures ($ billions)
Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Role of Regulation in Optimizing Medicine use KNH/UON Pharmacy Symposium Optimizing Medicine.
Key Areas of Research & Education Relevant to Pharmacy & Public Health Andy Stergachis, PhD, RPh Schools of Public Health and Pharmacy University of Washington.
ACCESS TO MEDICINES - POLICY AND ISSUES
Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)
Promoting Drug and Therapeutics Committees in the Developing World
METHODS TO STUDY DRUG SAFETY PROBLEMS animal experiments clinical trials epidemiological methods –spontaneous reporting case reports case series –Post-Marketing.
Definitions. Clinical pharmacy is the branch of Pharmacy where pharmacists provide patient care that optimizes the use of medication and promotes health,
Technical Briefing Seminar September |1 | Methods to study medicine safety problems Mary R Couper Quality Assurance and Safety of Medicines.
Dr Shanthi Pal Quality Assurance and Safety of Medicines WHO
Project no_File reference IMS Health Baltic September 2005 Baltic pharma market 1999 – 2004 Developments, changes and possible future trends.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
Introduction.
Dr Mary Couper Quality Assurance and Safety of Medicines WHO
Pharmacovigilance WHO definition
Single Competency Framework for Prescribers National Prescribing Centre (2012)
In the Best Interests of the Public Health... Janice Soreth, M.D. Acting Director Division of Anti-Infective Drug Products CDER/FDA.
Medicines Reconciliation A Whole System Approach Arlene Coulson Principal Clinical Pharmacist, Specialist Services Gordon Thomson Principal Clinical Pharmacist,
ARRRR! Drug Development and Discovery Access to Essential Medicines De-Cal Fall Week 2.
1 PRIORITY MEDICINES FOR EUROPE AND THE WORLD Barriers to Pharmaceutical Innovation Richard Laing EDM/PAR WHO.
Resource Creation: Health Technologies in Support of System Development Adham R Ismail, MS, MBA, PhD Biomedical Engineer Department of Health Systems &
PHARMA HELPLINE SOCIETY we care,we assist, we help Announces on line courses for the overall development of pharmacy professionals and students. These.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
iHEA 9th World Congress Sydney, July 8, 2013
RAC Regulatory Affairs Certification
The utilisation of drugs (medicines) is reflected and described in the
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Italy - Evidence package
Risk Communication in Medicines
Namibian Medical Society Health Economic Seminar 18th April 2015
Quality Assurance and Safety of Medicines
Pharmacist- Career Opportunities
SELF CARE FACTORY EMPOWERMENT.
WHO EMP update for IPC June 2016
AIKTC - School of Pharmacy
68.3 million errors (28% of total) cause moderate or serious harm
Therapeutic Drug Management Quality Project
Issues on Dispensing Dr Percy Mahlathi.
Quality Assurance and Safety of Medicines
Compounded Drugs and Lack of Premarket FDA-Approval
Presentation transcript:

Health Services Research and Practice: Pharmaceuticals Andy Stergachis, Ph.D. R.Ph. Epidemiology and Pharmacy

Topics n Medication Use n Variations in Drug-Related Services n Pharmacoepidemiology & Drug Safety

Rx Expenditures: selected countries $US Bil Source: IMS HEALTH: MIDAS, 2001 * Pharmacy only ** Hospital only Sales Rx

Rx Spending Per Capita Source: OECD Health Data, 1999 Rx

Variations in Drug-Related Services n Pharmacies and pharmacists n Financing n Advertising and promotion n OTCs and drug schedules n Drug approval n Complementary medicine

71%11%12%4%2% 6, , PRECLINICAL PHASE IPHASE IIPHASE III PRE-REG Source: IMS Lifecycle CD ROM December Global Pipeline To December 2001  8,722 Products New Product s

Sources of Risk from Medical Products

Pharmacoepidemiology as a Continuum n Surveillance/Signal Generation u Adverse event reports n Verify/Confirm and Quantify Risk u Case-control and cohort studies n Improved Patient Care and Regulatory Decision Making u Risk-to-benefit

Issues n Affordability, access and equity n How safe is safe enough? n Variations in pharmacy practice n Variations in regulatory agencies n Drug reimportation concerns n Patterns of use, e.g., antimicrobial resistance

More Information n n Humanitarian Organizations (for example): n Other Organizations (eg. pharmacoepi.org) n